Get access to the exclusive HR Resources you need to succeed in 2018.
Sign up for free email newsletters and get more SHRM content delivered to your inbox.
Is your employee handbook keeping up with the changing world of work? With SHRM's Employee Handbook Builder get peace of mind that your handbook is up-to-date.
Build competencies, establish credibility and advance your career—while earning PDCs—at SHRM Seminars in 14 cities across the U.S. this fall.
Gain the skills you need to rise to the next level in your career. Jon us at SHRM's Leadership Development Forum, October 2-3 in Boston.
Study finds a 19 percent increase in specialty-drug spending in 2012
Members may download one copy of our sample forms and templates for your personal use within your organization. Please note that all such forms and policies should be reviewed by your legal counsel for compliance with applicable law, and should be modified to suit your organization’s culture, industry, and practices. Neither members nor non-members may reproduce such samples in any other way (e.g., to republish in a book or use for a commercial purpose) without SHRM’s permission. To request permission for specific items, click on the “reuse permissions” button on the page where you find the item.
Spending on high-cost specialty drugs used to treat complex diseases such as cancer jumped by more than 19 percent in 2012 among members of pharmacy benefit manager (PBM) Prime Therapeutics LLC. In contrast, Prime experienced a 0.9 percent drop in traditional (all nonspecialty) drug spending last year.
A new report by the PBM,
Specialty: Today & Tomorrow, highlights specialty-drug costs over the past year and recommends strategies to manage their steady rise.
“With the rising use of specialty drugs, the days of 1 to 2 percent increases in annual drug spending are nearing an end,” said Peter Wickersham, Prime’s senior vice president of cost of care. “We are clearly entering a time of higher costs, and plan sponsors that act now will be in the best position to assure quality care for their members while managing these high costs.”
Specialty drugs now account for 30 percent of total drug costs; Prime predicts they will reach 50 percent of total drug spending by 2018.
The following cost-controlling steps are outlined in the report:
Short videos about each of these steps are on Prime’s YouTube channel.
“Plan sponsors that are best managing specialty costs have the above actions in common,” said Duane Barnes, Prime’s senior vice president of consumer delivery. “By deploying these steps and taking a comprehensive approach to understanding specialty costs, plans can help their members access these important medicines and use them safely and effectively.”
is an online editor/manager for SHRM.
Related External Article
Related SHRM Articles
You have successfully saved this page as a bookmark.
Please confirm that you want to proceed with deleting bookmark.
You have successfully removed bookmark.
Please log in as a SHRM member before saving bookmarks.
Please sign in as a SHRM member before saving bookmarks.
Please purchase a SHRM membership before saving bookmarks.
An error has occurred
Recommended for you
Become a SHRM Member
SHRM’s HR Vendor Directory contains over 10,000 companies